Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.

Stephen DLawn; (2011) Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes. The international journal of tuberculosis and lung disease, 15 (9). pp. 1272-1273. ISSN 1027-3719 DOI: 10.5588/ijtld.11.0407
Copy
Item Type Article
ISI 294520900027

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads

Full text not available from this repository.

Explore Further

Find work associated with the faculties and division(s):

Find work from this publication: